Market Snapshot

High-signal KPIs designed for executive scanning.

Indicative snapshot. Request sample for full model outputs.

Market Size (latest)

—

— vs. prior year

CAGR

—

Forecast window: —

Forecast Period

2024–2031

Base years: 2019–2023

Coverage Depth

—

Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.

The global Antimicrobial Resistance (AMR) market was valued at USD 9.4 billion in 2023 and is projected to reach USD 21.6 billion by 2031, growing at a CAGR of 10.9%. Novel drug development, rapid diagnostics, and AI-powered solutions to combat superbugs are transforming the market.

2024 Market Breakthroughs

Phage Therapy Commercialization:
- Adaptive Phage Therapeutics' FDA-approved phage cocktail treats all tested MRSA cases with a success rate of 100%.
- Locus Biosciences' CRISPR-engineered phages reduce E. coli infections by 99% in trials.
AI-Drug Discovery:
- Exscientia's AI-designed antibiotic (XAI-101) demonstrates ten times the potency against gram-negative bacteria.
- BenevolentAI's platform identified three novel AMR targets in 2024.
Rapid Diagnostics:
- Cepheid's Xpert® Carba-R detects carbapenem resistance in 45 minutes (vs. 3 days).
- Oxford Nanopore's handheld sequencer identifies resistance genes in real-time.

Market Drivers

1. Rising Superbug Threats

1.27 million deaths/year directly attributable to AMR (WHO 2024).
Carbapenem-resistant infections increased 350% since 2015.

2. Policy & Funding Shifts

US PASTEUR Act guarantees USD 3B/year for novel antibiotics through 2030.
EU's AMR Action Plan mandates 50% reduction in human antibiotic use by 2025.

3. Diagnostic Advancements

FDA's 2024 Breakthrough Device Designation for 5 rapid AMR tests.
Reimbursement reforms now pay hospitals for diagnostic-guided therapy.

Competitive Landscape

Company	Market Share	Flagship Product	Strategic Edge
Merck & Co.	25%	Relebactam (β-lactamase inhibitor)	Hospital formulary dominance
Shionogi	20%	Cefiderocol (siderophore antibiotic)	Novel iron-uptake mechanism
Thermo Fisher	15%	AMR Gene Panels	Gold-standard diagnostics

Emerging Disruptors:

Nobio: Antimicrobial polymers for medical devices (FDA-cleared in 2024).
Day Zero Diagnostics: AI-powered genome sequencing for outbreak tracing.

Market Segmentation

By Product:
- Drugs (60%): Novel antibiotics dominate.
- Diagnostics (XX%): Fastest-growing segment (18% CAGR).
- Prevention (XX%): Surface coatings, vaccines.
By Pathogen:
- Gram-Negative (XX%): K. pneumoniae, P. aeruginosa.
- Gram-Positive (XX%): MRSA, VRE.
By Region:
- North America (XX%): Leading in novel drug development.
- Europe (XX%): Strongest AMR stewardship policies.
- Asia-Pacific (XX%): High antibiotic misuse driving resistance.

Recent Developments (2024)

May 2024: FDA fast-tracks XAI-101 for XDR A. baumannii.
August 2024: EU approves first phage therapy for chronic wounds.

Unlock the executive summary.

Request the sample to review key questions answered.

See what’s included.

Request sample for scope, definitions and segmentation.

Key Players

Anti-Microbial Resistance Market – Pfizer Inc.
Merck & Co. Inc.
GlaxoSmithKline plc
Johnson & Johnson
Sanofi
Novartis AG
Bayer AG
Eli Lilly and Company
AstraZeneca plc
Roche Holding AG.

Competitive Dashboard Preview

Shortlist strategic accounts and benchmark positioning.

Loading…

Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.

Refine View

Geography Segment Sub-segment

—

Request A Custom Cut

Opportunity Index

Directional signals for prioritization and scenario framing.

Interactive

Need a board-ready slide? .

Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Global Anti-Microbial Resistance Market Report

1. Global Anti-Microbial Resistance Market Research Report
1. 1.1 Study Objectives
2. 1.2 Global Anti-Microbial Resistance Market - Overview
3. 1.3 Reason to Read This Report
4. 1.4 Methodology and Forecast Analysis
2. Global Anti-Microbial Resistance Market Research Report - Preface
1. 2.1 Global Anti-Microbial Resistance Market Research Report – Detailed Scope and Definitions
  1. 2.1.1 By Pathogen Type
  2. 2.1.2 By Drug Type
  3. 2.1.3 By Application
  4. 2.1.4 By Region
3. Global Anti-Microbial Resistance Market Dynamics
1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
2. 3.2. Restraints – By Pathogen Type, By Drug Type, By Application, By Country
3. 3.3. Opportunities – By Pathogen Type, By Drug Type, By Application, By Country
4. 3.4. Trends – By Pathogen Type, By Drug Type, By Application, By Country
5. 3.5. PEST Analysis
6. 3.6. Porters Five Rule Analysis
7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
8. 3.8. Global Anti-Microbial Resistance Market Research Report – DROTs Impact Analysis
4. Global Anti-Microbial Resistance Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. Global Anti-Microbial Resistance Market, By Pathogen Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 5.1 Bacteria
  1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 5.2 Viruses
  1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 5.3 Fungi
  1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Global Anti-Microbial Resistance Market, By Drug Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 6.1 Antibiotics
  1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 6.2 Antifungals
  1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 6.3 Antivirals
  1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. Global Anti-Microbial Resistance Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 7.1 Hospitals
  1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 7.2 Clinics
  1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 7.3 Outpatient Settings.
  1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. Global Anti-Microbial Resistance Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
1. 8.1 North America
  1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 8.2 Europe
  1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 8.3 Asia-Pacific
  1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 8.4 Latin America
  1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 8.5 Middle East & Africa
  1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 8.6 Global Anti-Microbial Resistance Market - Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Region, 2024 - 2031
9. North America Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 9.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.1.1 Bacteria
  2. 9.1.2 Viruses
  3. 9.1.3 Fungi
  9.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.2.1 Antibiotics
  2. 9.2.2 Antifungals
  3. 9.2.3 Antivirals
  9.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.3.1 Hospitals
  2. 9.3.2 Clinics
  3. 9.3.3 Outpatient Settings.
  9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.4.1 United States
  2. 9.4.2 Canada
  9.5 North America Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
  9.6 Regional Trends Analysis
  9.7 North America Global Anti-Microbial Resistance Market Research Report - Company Profiles
  1. 9.7.1 Company 1 (United States)
  2. 9.7.2 Company 2 (Canada)
  3. 9.7.3 Company 3 (Canada)
10. Europe Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 10.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.1.1 Bacteria
  2. 10.1.2 Viruses
  3. 10.1.3 Fungi
  10.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.2.1 Antibiotics
  2. 10.2.2 Antifungals
  3. 10.2.3 Antivirals
  10.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.3.1 Hospitals
  2. 10.3.2 Clinics
  3. 10.3.3 Outpatient Settings.
  10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.4.1 Germany
  2. 10.4.2 United Kingdom
  3. 10.4.3 France
  4. 10.4.4 Spain
  5. 10.4.5 Italy
  6. 10.4.6 Russia
  7. 10.4.7 Netherlands
  8. 10.4.8 Poland
  9. 10.4.9 Rest of Europe
  10.5 Europe Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
  10.6 Regional Trends Analysis
  10.7 Europe Global Anti-Microbial Resistance Market Research Report - Company Profiles
  1. 10.7.1 Company 1 (Germany)
  2. 10.7.2 Company 2 (United Kingdom)
  3. 10.7.3 Company 3 (United Kingdom)
11. Asia-Pacific Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 11.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.1.1 Bacteria
  2. 11.1.2 Viruses
  3. 11.1.3 Fungi
  11.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.2.1 Antibiotics
  2. 11.2.2 Antifungals
  3. 11.2.3 Antivirals
  11.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.3.1 Hospitals
  2. 11.3.2 Clinics
  3. 11.3.3 Outpatient Settings.
  11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.4.1 China
  2. 11.4.2 Japan
  3. 11.4.3 India
  4. 11.4.4 South Korea
  5. 11.4.5 Australia & NZ
  6. 11.4.6 ASEAN
  7. 11.4.7 Rest of Asia-Pacific
  11.5 Asia-Pacific Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
  11.6 Regional Trends Analysis
  11.7 Asia-Pacific Global Anti-Microbial Resistance Market Research Report - Company Profiles
  1. 11.7.1 Company 1 (China)
  2. 11.7.2 Company 2 (Japan)
  3. 11.7.3 Company 3 (Japan)
12. Latin America Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 12.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.1.1 Bacteria
  2. 12.1.2 Viruses
  3. 12.1.3 Fungi
  12.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.2.1 Antibiotics
  2. 12.2.2 Antifungals
  3. 12.2.3 Antivirals
  12.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.3.1 Hospitals
  2. 12.3.2 Clinics
  3. 12.3.3 Outpatient Settings.
  12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.4.1 Brazil
  2. 12.4.2 Mexico
  3. 12.4.3 Argentina
  4. 12.4.4 Peru
  5. 12.4.5 Colombia
  6. 12.4.6 Rest of Latin America
  12.5 Latin America Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
  12.6 Regional Trends Analysis
  12.7 Latin America Global Anti-Microbial Resistance Market Research Report - Company Profiles
  1. 12.7.1 Company 1 (Brazil)
  2. 12.7.2 Company 2 (Mexico)
  3. 12.7.3 Company 3 (Mexico)
13. Middle East & Africa Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 13.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.1.1 Bacteria
  2. 13.1.2 Viruses
  3. 13.1.3 Fungi
  13.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.2.1 Antibiotics
  2. 13.2.2 Antifungals
  3. 13.2.3 Antivirals
  13.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.3.1 Hospitals
  2. 13.3.2 Clinics
  3. 13.3.3 Outpatient Settings.
  13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.4.1 Saudi Arabia
  2. 13.4.2 UAE
  3. 13.4.3 South Africa
  4. 13.4.4 Egypt
  5. 13.4.5 Israel
  6. 13.4.6 Rest of Middle East and Africa
  13.5 Middle East & Africa Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
  13.6 Regional Trends Analysis
  13.7 Middle East & Africa Global Anti-Microbial Resistance Market Research Report - Company Profiles
  1. 13.7.1 Company 1 (Saudi Arabia)
  2. 13.7.2 Company 2 (UAE)
  3. 13.7.3 Company 3 (UAE)
14. Competition Landscape
1. 14.1 Strategic Dashboard of Top Market Players
  14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
  1. 14.2.1 Anti-Microbial Resistance Market – Pfizer Inc.
  2. 14.2.2 Merck & Co. Inc.
  3. 14.2.3 GlaxoSmithKline plc
  4. 14.2.4 Johnson & Johnson
  5. 14.2.5 Sanofi
  6. 14.2.6 Novartis AG
  7. 14.2.7 Bayer AG
  8. 14.2.8 Eli Lilly and Company
  9. 14.2.9 AstraZeneca plc
  10. 14.2.10 Roche Holding AG.
15. Data Collection Method and Research Approach
16. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.

Triangulated Sizing

Bottom-up, top-down, and peer benchmarks reconciled by analysts.

Primary + Secondary Research

Executive interviews combined with validated public and paid sources.

Scenario & Sensitivity

Base, bull and bear cases to stress-test strategic moves.

Book A Consultation

Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.

Global Glioma Diagnosis and Treatment Market & Competitive Intelligence, 2019 to 2024, Forecast 2025 to 2031 Research Report

CVMI24071660 Jan. 30, 2026

$3600.00 single user

View report →

Global Under-Arm Exoskeletons Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI0112 Dec. 1, 2025

$3600.00 single user

View report →

Global LED Lip Masks Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30115 Dec. 1, 2025

$3600.00 single user

View report →

Global Advanced Musculoskeletal Care Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30116 Dec. 1, 2025

$3600.00 single user

View report →

Global Light-Powered Joint Support Systems Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30114 Nov. 30, 2025

$3600.00 single user

View report →

Global Wearable Medical-Grade Cold Lasers Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI3011 Nov. 30, 2025

$3600.00 single user

View report →

Global Dual Microcurrent Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30113 Nov. 30, 2025

$3600.00 single user

View report →

Global Wearable Light Therapy Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30112 Nov. 30, 2025

$3600.00 single user

View report →

Global Targeted Air Compression Therapies Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI2711 Nov. 27, 2025

$3600.00 single user

View report →

Global Wearable Light-Emitting Diodes (LEDs) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI27111 Nov. 27, 2025

$3600.00 single user

View report →

Global Robotic Hand Assistance Solutions Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI2611 Nov. 26, 2025

$3600.00 single user

View report →

Istanbul Hair Transplant Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI26081 Aug. 26, 2025

$3600.00 single user

View report →

Ready to move from data to decision?

Get the report, request a sample, or book a consultative briefing.

Buy Report Talk To An Analyst

Global Anti-Microbial Resistance Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis 2024 - 2031

Market Snapshot

Insights

Key Players

Segmentation Explorer

Table Of Contents

Global Anti-Microbial Resistance Market Report

Methodology & Credibility

Related Reports